4.5 Article

Preoperative peripheral blood neutrophil-to-lymphocyte ratios (NLR) and platelet-to-lymphocyte ratio (PLR) related nomograms predict the survival of patients with limited-stage small-cell lung cancer

Journal

TRANSLATIONAL LUNG CANCER RESEARCH
Volume 10, Issue 2, Pages 866-+

Publisher

AME PUBLISHING COMPANY
DOI: 10.21037/tlcr-20-997

Keywords

Limited-stage small-cell lung cancer (LS-SCLC); neutrophil-to-lymphocyte ratio (NLR); platelet-to-lymphocyte ratio (PLR); prognosis

Funding

  1. National Natural Science Foundation of China [81773007]
  2. Shanghai Municipal Human Resources and Social Security Bureau [201706]
  3. Three-year Action Plan Project for Promoting Clinical Skills and Clinical Innovation in Municipal Hospitals [16CR2013A]
  4. Shanghai Municipal Commission of Health and Family Planning [2017YQ018]

Ask authors/readers for more resources

The study aimed to establish NLR and PLR related nomograms based on clinical data and peripheral blood markers to predict the survival of LS-SCLC patients. Elevated NLR and PLR were found to predict poor prognosis in their respective nomograms, showing better accuracy and stability compared to the TNM staging system. The models had a better effect in predicting prognosis as indicated by C-index and calibration curves.
Background: We aim to establish neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) related nomograms based on the clinical data and peripheral blood markers to predict the survivals of patients with limited-stage small-cell lung cancer (LS-SCLC). Methods: A total of 299 LS-SCLC patients after surgery were enrolled in this study. Univariate and multivariate analyses were conducted to select independent prognostic factors to develop the nomograms and then subjected to bootstrap internal validation. The optimal cutoff value of NLR and PLR before surgery was calculated by X-tile (version 3.6.1) and the overall survival (OS) was analyzed by Kaplan-Meier method and compared by log-rank test. Results: According to the X-tile calculation, the NLR value and PLR cutoff values are 2.6 and 156.7, respectively. The prognosis of patients with elevated NLR or PLR value was significantly worse than patients with lower NLR (HR =1.798, 95% CI: 1.284-2.518, P=0.001) or PLR (HR =1.781, 95% CI: 1.318-2.407, P<0.001) value. Two Nomograms were developed according to the two multivariate cox regression models based on NLR and PLR. Concordance index (C-index) curves and calibration curves show that the two models have a better effect in predicting prognosis. At the same time, compared with the tumor node metastasis (TNM) staging system, our models also show better accuracy and stability. Conclusions: Elevated NLR and PLR predict poor prognosis in their respective nomograms in patients with LS-SCLC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Metabolic synthetic lethality by targeting NOP56 and mTOR in KRAS-mutant lung cancer

Zhang Yang, Shun-Qing Liang, Liang Zhao, Haitang Yang, Thomas M. Marti, Balazs Hegedus, Yanyun Gao, Bin Zheng, Chun Chen, Wenxiang Wang, Patrick Dorn, Gregor J. Kocher, Ralph A. Schmid, Ren-Wang Peng

Summary: This study reveals the metabolic dependency induced by mutant KRAS and identifies nucleolar protein 5A (NOP56) and mTOR as potential targets for the treatment of KRAS-mutant cancers. The depletion of NOP56 leads to synthetic lethal susceptibility to mTOR inhibition due to the regulation of ROS homeostasis. Co-targeting NOP56 and mTOR significantly enhances cell death in KRAS-mutant tumor cells.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)

Article Medicine, Research & Experimental

Tumor-infiltrating lymphocytes are functionally inactivated by CD90+stromal cells and reactivated by combined Ibrutinib and Rapamycin in human pleural mesothelioma

Haitang Yang, Sabina Berezowska, Patrick Dorn, Philipp Zens, Peiru Chen, Ren-Wang Peng, Thomas M. Marti, Gregor J. Kocher, Ralph A. Schmid, Sean R. R. Hall

Summary: This study investigates the relationship between the tumor microenvironment (TME) and tumor-infiltrating lymphocytes (TILs) in malignant pleural mesothelioma (MPM). The results suggest that targeting the TME can potentially redirect the fate of TILs and restore anti-tumor immunity in MPM.

THERANOSTICS (2022)

Article Oncology

Functional and molecular characterization of PD1+ tumor-infiltrating lymphocytes from lung cancer patients

Jesse J. Lipp, Limei Wang, Haitang Yang, Feng Yao, Nathalie Harrer, Stefan Muller, Sabina Berezowska, Patrick Dorn, Thomas M. Marti, Ralph A. Schmid, Belazs Hegedus, Abdallah Souabni, Sebastian Carotta, Mark A. Pearson, Wolfgang Sommergruber, Greg J. Kocher, Sean R. R. Hall

Summary: This study investigates the effect of PD1 expression on the functional and molecular profiles of tumor-resident T cells in non-small cell lung cancer patients. They find that PD1+ CD8+ T cells have elevated expression of the transcriptional regulator ID3 and that knocking down ID3 improves the cytotoxic potential of these cells. Additionally, PD1+ CD4+ memory T cells can facilitate B cell activation and expansion. Restoring WNT signaling by blocking GSK3 beta improves the effector function of PD1+ CD8+ T cells.

ONCOIMMUNOLOGY (2022)

Letter Oncology

Implementation of smoking signature as an improved biomarker predicting the response to Immunotherapy

Haitang Yang, Wenyan Ma, Feng Yao

TRANSLATIONAL LUNG CANCER RESEARCH (2022)

Article Respiratory System

Indocyanine green fluorescence-navigated thoracoscopy versus traditional inflation-deflation approach in precise uniportal segmentectomy: a short-term outcome comparative study

Wenbin Fan, Haitang Yang, Jie Ma, Zhexin Wang, Heng Zhao, Feng Yao

Summary: The present study compares the short-term outcomes of indocyanine green fluorescence (ICGF) versus the traditional inflation-deflation method for uniportal video-assisted thoracoscopic surgery (VATS) segmentectomy. The results show that the ICGF-based navigation approach is a simple and effective technique that can greatly facilitate the uniportal VATS segmentectomy.

JOURNAL OF THORACIC DISEASE (2022)

Letter Oncology

Revisiting BAP1ness in Malignant Pleural Mesothelioma

Haitang Yang, Feng Yao, Ren-Wang Peng

JOURNAL OF THORACIC ONCOLOGY (2022)

Article Physics, Particles & Fields

Echoes from hairy black holes

Guangzhou Guo, Peng Wang, Houwen Wu, Haitang Yang

Summary: This study investigates the waveforms of time signals produced by scalar perturbations in static hairy black holes. The waveforms are influenced by a double-peak effective potential. When the distance between the peaks is large, a series of decaying echo pulses are generated. However, when the peaks are close, fewer echo signals and a slowly decaying sinusoid tail are observed.

JOURNAL OF HIGH ENERGY PHYSICS (2022)

Article Medicine, General & Internal

Multi-scale characterization of tumor-draining lymph nodes in resectable lung cancer treated with neoadjuvant immune checkpoint inhibitors

Haitang Yang, Beibei Sun, Wenyan Ma, Liwen Fan, Ke Xu, Yunxuan Jia, Jianlin Xu, Zhexin Wang, Feng Yao

Summary: By studying the response of metastatic lymph nodes and primary tumors in lung cancer patients treated with immune checkpoint inhibitors, we found significant differences in radiological, metabolic, and pathological changes between the two. The presence of invaded lymph nodes was associated with poor pathological responses in primary tumors and predicted rapid tumor relapse after treatment.

EBIOMEDICINE (2022)

Review Medicine, Research & Experimental

Battles against aberrant KEAP1-NRF2 signaling in lung cancer: intertwined metabolic and immune networks

Ke Xu, Jie Ma, Sean R. R. Hall, Ren-Wang Peng, Haitang Yang, Feng Yao

Summary: The hyperactivation of the KEAP1/NRF2 pathway in non-small cell lung cancer leads to metabolic reprogramming and immune remodeling, contributing to the aggressiveness, treatment resistance, and susceptibility to metastases of the cancer cells.

THERANOSTICS (2023)

Article Chemistry, Multidisciplinary

Multienzyme-Mimicking LaCoO3 Nanotrigger for Programming Cancer-Cell Pyroptosis

Ke Xu, Meiqi Chang, Zeyu Wang, Haitang Yang, Yunxuan Jia, Weijiao Xu, Baicheng Zhao, Yu Chen, Feng Yao

Summary: In this study, LaCoO3 (LCO) lanthanide-based nanocrystals were designed to trigger lung cancer cell pyroptosis by generating cytotoxic reactive oxygen species (ROS) and releasing lanthanum ions. The LCO nanoenzyme exhibited peroxidase- and oxidase-mimicking activities, producing ROS in the tumor microenvironment. It also reversed the hypoxic environment, destroying the antioxidant system of tumor cells and increasing their sensitivity to ROS. LCO-induced pyroptotic cell death effectively restrained lung cancer growth and metastasis.

ADVANCED MATERIALS (2023)

Article Cell Biology

MEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesothelioma

Haitang Yang, Yanyun Gao, Duo Xu, Ke Xu, Shun-Qing Liang, Zhang Yang, Amina Scherz, Sean R. R. Hall, Stefan Forster, Sabina Berezowska, Feng Yao, Adrian F. F. Ochsenbein, Thomas M. M. Marti, Gregor J. J. Kocher, Ralph A. A. Schmid, Patrick Dorn, Ren-Wang Peng

Summary: Malignant pleural mesothelioma (MPM) is a lethal malignancy caused by asbestos exposure. In this study, we found that the hyperactive MAPK pathway is a molecular driver of MPM, and blocking this pathway induces cell apoptosis. Additionally, the MAPK pathway cooperates with PARP1 to regulate ROS levels, and combining MEK inhibitors with PARP inhibitors enhances cell apoptosis.

CELL DEATH DISCOVERY (2023)

Article Engineering, Biomedical

One-Pot Synthesis of Tumor-Microenvironment Responsive Degradable Nanoflower-Medicine for Multimodal Cancer Therapy with Reinvigorating Antitumor Immunity

Jiamin Sun, Kai Jiang, Yifan Wang, Yuqing Liu, Ting Wang, Shiyue Ding, Xianzhi Zhang, Weiwei Xiong, Fenfen Zheng, Haitang Yang, Jun-Jie Zhu

Summary: An easy-synthesized and biodegradable nanoflower-medicine that effectively suppresses tumor growth and reactivates antitumor immunity through tumor microenvironment (TME)-responsive sequential multimodal synergistic cancer therapy is designed. The proposed TME-responsive degradable nanoflower-medicine can be excreted through kidneys after implementing multimodal therapy, which is highly desirable in clinical precision oncology.

ADVANCED HEALTHCARE MATERIALS (2023)

Article Biochemistry & Molecular Biology

Phosphorylation by IKK8 Promotes the Degradation of HMGCL via NEDD4 in Cancer

Chenxi Zhong, Guosheng Xiong, Haitang Yang, Xiaohua Du, Jiankui Du, Feng Yao, Wentao Fang, Yuezhen Deng

Summary: This study found that the downregulation of 3-hydroxy-3-methylglutaryl-CoA lyase (HMGCL) in lung cancer was associated with larger tumor size and shorter overall survival time. Overexpression of HMGCL increased the content of 8-hydroxybutyrate (8-HB) and inhibited the tumorigenicity of lung cancer cells. Mechanistically, TNF alpha treatment decreased HMGCL protein level by phosphorylating it at Ser258 through IKK8, and NEDD4 promoted the degradation of HMGCL. These findings demonstrate a link between TNF alpha-mediated inflammation and cancer metabolism.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2023)

Article Medicine, Research & Experimental

IL-20RB mediates tumoral response to osteoclastic niches and promotes bone metastasis of lung cancer

Yunfei He, Wenqian Luo, Yingjie Liu, Yuan Wang, Chengxin Ma, Qiuyao Wu, Pu Tian, Dasa He, Zhenchang Jia, Xianzhe Lv, Yu-Shui Ma, Haitang Yang, Ke Xu, Xue Zhang, Yansen Xiao, Peiyuan Zhang, Yajun Liang, Da Fu, Feng Yao, Guohong Hu

Summary: This study revealed the role of IL-20RB in promoting bone metastasis of lung cancer. IL-20RB facilitated the growth of lung cancer cells in the bone by activating JAK1/STAT3 signaling. Blocking IL-20RB significantly suppressed the bone metastasis of lung cancer.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Article Medicine, Research & Experimental

Multi-scale integrative analyses identify THBS2+cancer-associated fibroblasts as a key orchestrator promoting aggressiveness in early-stage lung adenocarcinoma

Haitang Yang, Beibei Sun, Liwen Fan, Wenyan Ma, Ke Xu, Sean R. R. Hall, Zhexin Wang, Ralph A. Schmid, Ren-Wang Peng, Thomas M. Marti, Wen Gao, Jianlin Xu, Weiwei Yang, Feng Yao

Summary: In this study, we identified a specific cancer-associated fibroblast subset in lung adenocarcinoma patients that promotes an aggressive phenotype. We found that THBS2 is a biomarker that can predict post-surgical survival and is exclusively derived from this fibroblast subset.

THERANOSTICS (2022)

No Data Available